Selective in vitro inhibition of an antibody response to purified acetylcholine receptor by using anti-idiotypic antibodies coupled to the A chain of ricin
- PMID: 3490511
Selective in vitro inhibition of an antibody response to purified acetylcholine receptor by using anti-idiotypic antibodies coupled to the A chain of ricin
Abstract
In vitro antibody responses by rat lymph node cells against purified acetylcholine receptor (AChR) were shown to be inhibitable by protein conjugates prepared with anti-idiotypic antibody and the toxic A chain of ricin. The idiotype specificity of the cytotoxicity was demonstrated by the inability of the same immunotoxin to inhibit an unrelated antibody response (anti-KLH) and by abrogation of specific toxicity in the presence of unconjugated anti-idiotype or antigen (AChR). Furthermore, immunotoxin prepared with an irrelevant antibody specificity failed to significantly inhibit either the anti-AChR or control antibody responses. Therefore, we suggest that idiotype-specific immunotoxins may be a useful addition or alternative to presently employed immunotherapies for autoimmune disease.
Similar articles
-
Selective in vitro inhibition of an antibody response to purified acetylcholine receptor by using antigen-ricin A chain immunotoxin.J Immunol. 1985 Nov;135(5):3062-7. J Immunol. 1985. PMID: 3876374
-
Whole ricin and recombinant ricin A chain idiotype-specific immunotoxins for therapy of the guinea pig L2C B cell leukemia.J Immunol. 1987 Jun 15;138(12):4502-8. J Immunol. 1987. PMID: 3495593
-
Specific killing of lymphocytes that cause experimental autoimmune myasthenia gravis by ricin toxin-acetylcholine receptor conjugates.J Immunol. 1984 Nov;133(5):2549-53. J Immunol. 1984. PMID: 6332854
-
Neoplastic B cells as targets for antibody-ricin A chain immunotoxins.Immunol Rev. 1982;62:159-83. doi: 10.1111/j.1600-065x.1982.tb00393.x. Immunol Rev. 1982. PMID: 7042537 Review. No abstract available.
-
The specification of the immune response revisited.Surv Immunol Res. 1982;1(2):173-83. doi: 10.1007/BF02918343. Surv Immunol Res. 1982. PMID: 6314467 Review. No abstract available.
Cited by
-
Therapeutic treatment of New Zealand mouse disease by a limited number of anti-idiotypic antibodies conjugated with neocarzinostatin.J Clin Invest. 1990 Sep;86(3):769-76. doi: 10.1172/JCI114773. J Clin Invest. 1990. PMID: 2144300 Free PMC article.